日本慢性肢体威胁性缺血患者行胫/足部旁路术采用单段大隐静脉移植物的临床结局
多普勒超声(DUS)评估直径≥2.5 mm和CT评估直径≥3.0 mm与一期通畅率改善显著相关。
要点
- 日本CLTI患者单段GSV旁路术后3年一期通畅率57.1%,二期通畅率79.6%。
- DUS评估直径≥2.5 mm和CT评估直径≥3.0 mm与一期通畅率改善独立相关。
- 约20%术前直径<2.5 mm的移植物在调整后二期通畅率、保肢和创面愈合相当。
核心结论
- 在日本CLTI队列中,DUS和CT评估的移植物直径与移植物通畅率显著相关,但与保肢或创面愈合无关。
- 亚洲CLTI患者中合适的移植物直径仍需进一步研究。
研究设计与样本
- 其中871例患者(72.0%男性;平均年龄73±10岁)接受单段GSV移植物,术前静脉直径通过DUS、CT或两者评估。
- 静脉直径按评估方法分为三组:<2.5 mm、2.5-3.0 mm和≥3.0 mm。
- 主要终点为一期通畅率;次要终点包括二期通畅率、保肢和创面愈合。
主要发现
- 871例单段GSV移植患者3年一期和二期通畅率分别为57.1%和79.6%。
- DUS评估直径≥2.5 mm和CT评估直径≥3.0 mm(反映平均差异0.30 mm)在调整患者背景和手术特征后与一期通畅率改善显著相关。
- 约20%病例术前直径<2.5 mm,调整后这些移植物的3年二期通畅率、保肢和创面愈合与较大直径移植物相当。
关键数值与推荐
- DUS评估直径≥2.5 mm与一期通畅率改善显著相关。
- CT评估直径≥3.0 mm与一期通畅率改善显著相关(DUS与CT评估直径平均差异0.30 mm)。
- 直径<2.5 mm的移植物在调整后3年二期通畅率、保肢和创面愈合与较大直径移植物相当。
临床怎么用
- 对于日本CLTI患者行胫或足部旁路术,选择单段GSV移植物时,DUS评估直径≥2.5 mm或CT评估直径≥3.0 mm可能有助于改善一期通畅率。
- 术前直径<2.5 mm的GSV移植物仍可考虑使用,因调整后二期通畅率、保肢和创面愈合与较大直径移植物相当。
局限性
- 回顾性观察性研究设计可能引入选择偏倚和未测量混杂因素。
- 静脉直径评估方法(DUS、CT或两者)不完全统一,分组标准基于不同评估方法。
- 研究仅纳入日本患者,结论外推至其他亚洲人群需谨慎。
- 原文未报告多变量调整的具体混杂因素、随访完整性及中心间差异等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A single segment great saphenous vein (GSV) with a diameter ≥ 3.0 mm is widely accepted as the standard conduit for tibial and pedal bypass in chronic limb threatening ischaemia (CLTI) based on studies in European and American populations. However, this threshold may not be appropriate for Asian patients who generally have smaller body habitus and vein diameter. The aim of this study was to evaluate clinical outcomes and the optimal conduit diameter in Asian patients with CLTI undergoing tibial or pedal bypass. METHODS: Data were analysed from a multicentre retrospective observational study of 1 016 CLTI cases treated with tibial or pedal bypass using autologous vein conduits at seven Japanese centres between 2013 and 2022. Pre-operative vein diameters were assessed by duplex ultrasound (DUS), computed tomography (CT), or both, and were categorised into three groups (< 2.5 mm, 2.5 - 3.0 mm, and ≥ 3.0 mm) for each evaluation. The primary endpoint was primary patency. Secondary endpoints included secondary patency, limb salvage, and wound healing. RESULTS: Among 871 patients (72.0% men; mean age 73 ± 10 years) who received single segment GSV grafts, the three year primary and secondary patency rates were 57.1% and 79.6%, respectively. Limb salvage at 3 years was 90.9% and the twelve month wound healing rate was 83.8%. A DUS evaluated diameter ≥ 2.5 mm and a CT evaluated diameter ≥ 3.0 mm (reflecting a mean difference of 0.30 mm) were significantly associated with improved primary patency after adjustment for patient backgrounds and procedural characteristics. Although approximately 20% of cases had pre-operative diameters < 2.5 mm, these grafts showed comparable three year secondary patency, limb salvage, and wound healing after adjustment. CONCLUSION: DUS and CT evaluated graft diameters were significantly associated with graft patency, but not with limb salvage or wound healing in a Japanese cohort. Further studies of the appropriate graft diameter are needed in Asian patients with CLTI.
引用
- Kobayashi T, Takahara M, Kikuchi S, et al. Clinical Outcomes in Japanese Patients with Chronic Limb Threatening Ischaemia Undergoing Tibial and Pedal Bypass with a Single Segment Great Saphenous Vein Graft. Eur J Vasc Endovasc Surg. 2026. PMID: 42323006. doi:10.1016/j.ejvs.2026.06.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。